Position in SRZN
as of Jun 30, 2026
· filed Aug 12, 2026
Position Value
$5,232,868
+$3,314,688 QoQ
Shares Held
201,652
+206.2% QoQ
Ownership
1.72%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#18
of 70 holders
Holding Since
Sep 2021
20 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in SRZN Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026GEODE CAPITAL MANAGEMENT, LLC holds $21,877,569,550 across 521 Biotechnology names. SRZN ranks #234 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
6,017,848 | $2,989,245,636 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
2,625,810 | $1,637,297,566 | |
| 3 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
2,635,840 | $793,466,914 | |
| 4 | RVMD |
Revolution Medicines, Inc.
|
3,942,676 | $738,384,360 | |
| 5 | MRNA |
Moderna, Inc.
|
9,710,335 | $680,014,759 | |
| 6 | INCY |
Incyte Corp
|
4,750,735 | $538,543,319 | |
| 7 | RPRX |
Royalty Pharma plc
|
8,058,048 | $451,814,751 | |
| 8 | INSM |
INSMED Inc
|
4,220,155 | $449,952,925 |
All Filings in SRZN
Export CSV
20 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $5,232,868 | 201,652 | Shares | Defined | 2026-08-12 | |
| 2026-03-31 | $1,918,180 | 65,849 | Shares | Defined | 2026-05-15 | |
| 2025-12-31 | $1,514,086 | 66,995 | Shares | Defined | 2026-02-09 | |
| 2025-09-30 | $702,579 | 54,527 | Shares | Defined | 2025-11-12 | |
| 2025-06-30 | $276,808 | 30,963 | Shares | Defined | 2025-08-08 | |
| 2025-03-31 | $294,542 | 25,261 | Shares | Defined | 2025-05-13 | |
| 2024-12-31 | $321,310 | 22,391 | Shares | Defined | 2025-02-12 | |
| 2024-09-30 | $212,776 | 17,761 | Shares | Defined | 2024-11-12 | |
| 2024-06-30 | $204,851 | 18,708 | Shares | Defined | 2024-08-09 | |
| 2024-03-31 | $180,240 | 11,473 | Shares | Defined | 2024-05-13 | |
| 2023-12-31 | $107,846 | 11,473 | Shares | Defined | 2024-02-13 | |
| 2023-09-30 | $84,352 | 172,148 | Shares | Defined | 2023-11-13 | |
| 2023-06-30 | $94,572 | 171,950 | Shares | Defined | 2023-08-11 | |
| 2023-03-31 | $103,513 | 171,950 | Shares | Defined | 2023-05-15 | |
| 2022-12-31 | $100,074 | 171,950 | Shares | Defined | 2023-02-13 | |
| 2022-09-30 | $348,187 | 172,370 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $517,110 | 172,370 | Shares | Defined | 2022-08-12 | |
| 2022-03-31 | $518,833 | 172,370 | Shares | Defined | 2022-05-13 | |
| 2021-12-31 | $1,009,270 | 156,719 | Shares | Defined | 2022-02-11 | |
| 2021-09-30 | $910,056 | 128,539 | Shares | Defined | 2021-11-12 | |
| No filing history on record for this holder in this stock. | ||||||